Results 1 to 10 of about 202,297 (260)
Hypersensitivity pneumonitis [PDF]
This PrimeView highlights the mechanisms underlying Hypersensitivity pneumonitis, which is a syndrome caused by the inhalation of a variety of environmental antigens in susceptible and sensitized individuals.
Ulrich Costabel +2 more
exaly +9 more sources
Background Idiopathic pulmonary fibrosis (IPF) and chronic hypersensitivity pneumonitis share commonalities in pathogenesis shifting haemostasis balance towards the procoagulant and antifibrinolytic activity.
Małgorzata Sobiecka +10 more
doaj +2 more sources
Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It represents a collaborative effort among the American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana del Tórax. Methods: Systematic
Ganesh Raghu +2 more
exaly +2 more sources
RATIONALE Chronic hypersensitivity pneumonitis (CHP) is caused by an immune response to antigen inhalation and is characterized by variable histopathological and clinical features.
Haruhiko Furusawa +2 more
exaly +2 more sources
Concomitant diagnosis of hypersensitivity pneumonitis and localized epithelioid mesothelioma: a rare case report [PDF]
Hypersensitivity pneumonitis is an inflammatory lung disease caused by antigen inhalation after sensitization. Here, we report a rare case of the simultaneous diagnosis of hypersensitivity pneumonitis and epithelioid mesothelioma, a subtype of malignant ...
Simone de Leon Martini +7 more
doaj +2 more sources
Rituximab therapy in patients with treatment-refractory hypersensitivity pneumonitis [PDF]
Hypersensitivity pneumonitis (HP) presents with a highly variable clinical course, and traditional treatment includes systemic corticosteroids and strict antigen avoidance.
Yosri Akl +3 more
doaj +2 more sources
Clinical predictors of physiologic change after treatment with immunosuppression in hypersensitivity pneumonitis. [PDF]
IntroductionTreatment of hypersensitivity pneumonitis involves removal of the antigen and may include the use of immunosuppression or antifibrotic therapy.
Margaret Kypreos +6 more
doaj +2 more sources
Management and Resolution of Hypersensitivity Pneumonitis-Related Events in Japanese Patients Treated with Amikacin Liposome Inhalation Suspension in the CONVERT and INS-312 Clinical Trials [PDF]
In the phase 3 CONVERT trial, amikacin liposome inhalation suspension (ALIS) plus guideline-based therapy (GBT) achieved greater culture conversion than GBT alone in the treatment of refractory Mycobacterium avium complex pulmonary disease (MAC-PD).
Yoshitaka Yamazaki +5 more
doaj +2 more sources
Diagnosis, course and management of hypersensitivity pneumonitis
Hypersensitivity pneumonitis (HP) is a complex and heterogeneous interstitial lung disease (ILD) that occurs when susceptible individuals develop an exaggerated immune response to an inhaled antigen.
M. Hamblin, H. Prosch, M. Vašáková
semanticscholar +1 more source
Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Panel Report.
BACKGROUND The purpose of this analysis is to provide evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variability ...
Evans R. Fernández Pérez +15 more
semanticscholar +1 more source

